These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38159270)

  • 1. Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry.
    Ausejo-Mauleon I; Labiano S; Alonso MM
    STAR Protoc; 2024 Mar; 5(1):102803. PubMed ID: 38159270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine brain tumor microenvironment immunophenotyping using mass cytometry.
    McClellan BL; Alghamri MS; Thalla R; Lowenstein PR; Castro MG
    STAR Protoc; 2022 Jun; 3(2):101357. PubMed ID: 35634359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of the immune cell fraction from murine brain tumor microenvironment.
    Mastandrea I; Sher D; Magod P; Friedmann-Morvinski D
    STAR Protoc; 2022 Mar; 3(1):101106. PubMed ID: 35098162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol to analyze antitumor immunity of orthotopic injection and spontaneous murine high-grade glioma models using flow cytometry and single-cell RNA sequencing.
    Park JH; Kim CW; Kim HJ; Kim HJ; Lee JH; Lee HK
    STAR Protoc; 2022 Sep; 3(3):101607. PubMed ID: 35990740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models.
    Chen A; Chao Y; Zou H; McCarl LH; Kohanbash G; Hu B
    STAR Protoc; 2023 Mar; 4(1):102049. PubMed ID: 36861832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol to study the immune profile of syngeneic mouse tumor models.
    Miyauchi S; Arimoto KI; Liu M; Zhang Y; Zhang DE
    STAR Protoc; 2024 Sep; 5(3):103139. PubMed ID: 38878286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol to generate traceable CAR T cells for syngeneic mouse cancer models.
    Zhang D; Krimitza E; Han K; Su R; Xu DJ; Xu JR; Gong Y; Fan Y
    STAR Protoc; 2024 Mar; 5(1):102898. PubMed ID: 38367235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol to examine immune subpopulations in murine conjunctiva and lacrimal gland using flow cytometry.
    Ma B; Zhou Y; Duan H; Sun Z; Han W; Qi H
    STAR Protoc; 2024 Mar; 5(1):102921. PubMed ID: 38421865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for transcutaneous tumor photolabeling to track immune cells in vivo using Kaede mice.
    Dean I; Kennedy BC; Li Z; Berditchevski F; Withers DR
    STAR Protoc; 2024 Jun; 5(2):102956. PubMed ID: 38512866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing CD4 T cell differentiation in mouse small intestine using T cell transfer, lamina propria preparation, and flow cytometry.
    Duan J; Sun Y; Matute JD; Blumberg RS
    STAR Protoc; 2023 Sep; 4(3):102485. PubMed ID: 37566548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Optimized Protocol for In Vivo Analysis of Tumor Cell Division in a Sleeping Beauty-Mediated Mouse Glioma Model.
    Garcia-Fabiani MB; Kadiyala P; Lowenstein PR; Castro MG
    STAR Protoc; 2020 Sep; 1(2):. PubMed ID: 32984853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for the isolation of tumor cell-derived extracellular vesicles followed by in vivo metastasis assessment in a murine ovarian cancer model.
    Mittal S; Kumar S; Gupta P; Singh M; Chaluvally-Raghavan P; Pradeep S
    STAR Protoc; 2024 Jun; 5(2):102943. PubMed ID: 38470912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CyTOF protocol for immune monitoring of solid tumors from mouse models.
    Shin SM; Hernandez A; Coyne E; Munjal K; Gross NE; Charmsaz S; Yuan X; Yang H; Ho WJ
    STAR Protoc; 2023 Mar; 4(1):101949. PubMed ID: 36538397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system.
    Garcia-Fabiani MB; Comba A; Kadiyala P; Haase S; Núñez FJ; Altshuler D; Lowenstein PR; Castro MG
    Methods Enzymol; 2020; 632():369-388. PubMed ID: 32000905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for isolating single cells from human pancreatic cancer tissues and analyzing major immune cell populations using flow cytometry.
    Song J; Zhang J; Ji Y; Tang J; Sheng J; Liang T; Bai X
    STAR Protoc; 2023 Dec; 4(4):102679. PubMed ID: 37910511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol to identify and isolate rare murine tumor-resident dendritic cell populations for low-input transcriptomic profiling.
    Papadas A; Lagal DJ; Dou Y; Hong D; Gibbons A; Cicala A; Huang Y; Zomalan B; Molina E; Asimakopoulos F
    STAR Protoc; 2024 Sep; 5(3):103195. PubMed ID: 39096495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIM-3 blockade: immune and targeted therapy in DIPG.
    Hu Y; Hu P; Peng X
    Trends Mol Med; 2024 Feb; 30(2):110-112. PubMed ID: 38092623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for analyzing arginase I expression in tumor-associated myeloid-derived suppressor cells from murine colon cancer using flow cytometry.
    Zakeri A; Zhang K; Wang LL
    STAR Protoc; 2024 Sep; 5(3):103222. PubMed ID: 39088325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for density gradient neutrophil isolation and flow cytometry-based characterization from human peripheral blood.
    Kuang Y; Parthasarathy U; Martinelli R
    STAR Protoc; 2023 Sep; 4(3):102497. PubMed ID: 37590147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for evaluation of tumor-derived exosome-induced cancer cell metastasis in a mouse model.
    Lee YJ; Shin KJ; Chan Chae Y
    STAR Protoc; 2023 Sep; 4(3):102444. PubMed ID: 37436904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.